The prevalence of infectious diseases like tuberculosis, HIV/AIDS, meningitis, endocarditis, etc. has increased with growing unhealthy lifestyles. Increased hospital admissions are expected to be one of the most important factors contributing to the growth of the antibiotic susceptibility testing market. According to a report published by the World Health Organization, infectious diseases have been emerging at a rapid rate leading to an increase in demand for antibiotic susceptibility testing. According to the latest research by the company, the global antibiotic susceptibility testing market is expected to account for over US$ 4,054.4 Mn, in terms of value, by the end of 2028. The antibiotic susceptibility testing report further projects significant growth potential, with an average year-on-year growth rate pegged at 5.6% through 2028.
Antibiotic susceptibility testing conducted by several clinical microbiology labs is extremely important for confirming any sort of susceptibility to chosen antibiotic/antimicrobial agents or to further detect certain resistance in the bacteria isolated of an individual. Empirical therapy is an effective therapy for a few bacterial pathogens, as the resistance mechanism of these pathogens has not yet been observed. Certain individual isolates may possess acquired resistance mechanisms with species. Isolates such as members of Pseudomonas species, Enterococcus species, Staphylococcus species, and Streptococcus pneumoniae require antibiotic susceptibility testing. Antibiotic susceptibility testing for the control of antibiotic resistance mechanisms helps in indicating the antibiotic type which is apt for treating a particular infection further, avoiding unnecessary prescription of antibiotics in order to cut down on healthcare costs.
Antibiotic susceptibility testing allows targeting of key pathogens and addressing the most efficient treatment plan for an individual. Growing awareness about antibiotic susceptibility testing is expected to boost the demand for targeted antibiotic therapy further projecting market growth for the antibiotic susceptibility testing market during the forecast period. In July 2015, Wellcome Trust organized a workshop for examining the potential use of diagnostic tools for proper guidance of antibiotic usage in a range of common clinical scenarios. The growing demand for antibiotic therapy is expected to trigger market growth for antibiotic susceptibility testing.
Constant antibiotic susceptibility testing research, improved funding, and the development of novel antibiotic agents from different sources for antibiotic susceptibility testing as well as for being able to combat antibiotic resistance are major drivers for the market. Public-private investments and government funding for antibiotic susceptibility testing related research for better antibiotic evaluating and screening methods are gaining popularity. Various bioassays, like disk-diffusion, and agar or broth dilution, are commonly used. However, there are several other methods, such as bioluminescent and cytofluorometric, which are not widely used because they are equipment specific and require evaluation for standardization and reproducibility. Increased funding for these researches is expected to boost the antibiotic susceptibility testing market during the forecast period.
FMI has segmented the global antibiotic susceptibility testing market by product type, applications, and end user. By product type, the antibiotic susceptibility testing market is segmented into instruments, software & services, and kits & reagents. By instruments, the antibiotic susceptibility testing market is sub-segmented into Automated Broth Microdilution Systems, Manual Broth Microdilution Systems, and Semi-Automated Broth Microdilution Systems. By software & services, the antibiotic susceptibility testing market is sub-segmented into Image & Analysis Software and Installation Services. In terms of revenue, the Automated Broth Microdilution Systems segment in the antibiotic susceptibility testing market is expected to hold a significant share over the forecast period. By application, the antibiotic susceptibility testing market is segmented into Sepsis, Respiratory Infections, Gastrointestinal Infections, Meningitis & Encephalitis, Endocarditis, and Others. The others segment in the antibiotic susceptibility testing market is expected to witness limited growth during the forecast period. The respiratory infections segment is expected to grow at a robust CAGR and contribute a high revenue share in the antibiotic susceptibility testing market over the forecast period. The report tracks some of the key companies operating in the antibiotic susceptibility testing market, including BD, Danaher, Thermo Fischer Scientific, Bio-Rad Laboratories, Creative Diagnostics, Accelerate Diagnostics, Alifax, Liofilchem srl, bioMérieux SA, and Merck KgaA
A sample of this report is available upon request @https://www.futuremarketinsights.com/reports/sample/rep-gb-8574